4 results  1 of 1 

1 Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX
So Heun Lee, Dae Wook Hwang, Changhoon Yoo, Kyu-pyo Kim, Sora Kang, Jae Ho Jeong, Dongwook Oh, Tae Jun Song, Sang Soo Lee, Do Hyun Park, Dong Wan Seo, Jin-hong Park, Ki Byung Song, Jae Hoon Lee, Woohyung Lee, Yejong Park, Bong Jun Kwak, Heung-Moon Chang, Baek-Yeol Ryoo, Song Cheol Kim
Cancer Res Treat.2023;55(3):956-968.   Published online 2023 February 27     DOI: http://dx.doi.org/10.4143/crt.2022.409
      
2 Pancreaticoduodenectomy with combined hepatic artery and portal vein resection after laparoscopic division of pancreaticosplenic ligament due to FOLFIRINOX-induced hepatic toxicity related secondary hypersplenism
Ji Su Kim, Jeong Youp Park, Munseok Choi, Dong Jin Joo, Ho Kyoung Hwang, Woo Jung Lee, Chang Moo Kang
Ann Hepatobiliary Pancreat Surg.2021;25(2):307-312.   Published online 2021 May 31     DOI: http://dx.doi.org/10.14701/ahbps.2021.25.2.307
      
3 Extended distal pancreatectomy with thoracic wall resection after neoadjuvant FOLFIRINOX: Is there a limit of resection for pancreatic cancer after downstaging?
Tommaso Giuliani, Maria López Rubio, Eva Montalvá Oron, Javier Maupoey Ibañez, Andrea Boscá Robledo, Cecilia López Valdivia, Judith Pérez Rojas, Rafael Lopez Andujar
Ann Hepatobiliary Pancreat Surg.2020;24(1):90-96.   Published online 2020 February 27     DOI: http://dx.doi.org/10.14701/ahbps.2020.24.1.90
      
4 Impact of BRCA1/2 gene mutations on survival of patients with pancreatic cancer: A case-series analysis
Ernesto Barzola Navarro, Emilio Vicente López, Yolanda Quijano, Riccardo Caruso, Valentina Ferri, Hipolito Durand, Isabel Fabra Cabrera, Eduardo Diaz Reques, Benedetto Ielpo, Anastasiia Yuriyivna Glagolieva, Carlos Plaza
Ann Hepatobiliary Pancreat Surg.2019;23(2):200-205.   Published online 2019 May 31     DOI: http://dx.doi.org/10.14701/ahbps.2019.23.2.200
      

 1 of 1